Can Heart Failure Medications Prevent Trastuzumab-Induced Cardiotoxicity?

被引：1
|
作者：
Reynolds, Christopher C.
Hartlage, Gregory [1 ]
Chen, Ren [2 ]
Patel, Vinod
Guglin, Maya
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2009年 / 15卷 / 06期
关键词：
D O I：
10.1016/j.cardfail.2009.06.142
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
265
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] Independent and Incremental Value of Deformation Indices for Prediction of Trastuzumab-Induced Cardiotoxicity
    Negishi, Kazuaki
    Negishi, Tomoko
    Hare, James L.
    Haluska, Brian A.
    Plana, Juan Carlos
    Marwick, Thomas H.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2013, 26 (05) : 493 - 498
  • [32] Delayed Trastuzumab-induced Cardiotoxicity Leading to Severe Left Ventricular Dysfunction
    Misumi, Ikuo
    Nishimura, Reiki
    Nakamura, Shota
    Sato, Koji
    Dekita, Miwa
    Usuku, Hiroki
    Tsujita, Kenichi
    INTERNAL MEDICINE, 2024,
  • [33] Trastuzumab-Induced Cardiotoxicity: When and How Much Should We Worry?
    Zheng, Haoyi
    Mahmood, Syed S.
    Khalique, Omar K.
    Zhan, Huichun
    JCO ONCOLOGY PRACTICE, 2024, 20 (08)
  • [34] Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity
    Udagawa, Chihiro
    Nakamura, Hiromi
    Tamura, Kenji
    Shimoi, Tatsunori
    Yoshida, Masayuki
    Yoshida, Teruhiko
    Okamura, Hiroshi
    Totoki, Yasushi
    Shibata, Tatsuhiro
    Zembutsu, Hitoshi
    CANCER SCIENCE, 2018, 109 : 597 - 597
  • [35] Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity
    Udagawa, Chihiro
    Nakamura, Hiromi
    Ohnishi, Hiroshi
    Tamura, Kenji
    Shimoi, Tatsunori
    Yoshida, Masayuki
    Yoshida, Teruhiko
    Okamura, Hiroshi
    Totoki, Yasushi
    Shibata, Tatsuhiro
    Zembutsu, Hitoshi
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Chemotherapy and trastuzumab-induced cardiotoxicity in geriatric breast cancer patients.
    Agbisit, Christian
    Johnson, Alexander
    Robinson, Kathy
    Delfino, Kristin
    Desai, Meghna R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity
    Udagawa, Chihiro
    Nakamura, Hiromi
    Ohnishi, Hiroshi
    Tamura, Kenji
    Shimoi, Tatsunori
    Yoshida, Masayuki
    Yoshida, Teruhiko
    Totoki, Yasushi
    Shibata, Tatsuhiro
    Zembutsu, Hitoshi
    CANCER SCIENCE, 2018, 109 (02) : 446 - 452
  • [38] Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
    Cardinale, Daniela
    Colombo, Alessandro
    Torrisi, Rosalba
    Sandri, Maria T.
    Civelli, Maurizio
    Salvatici, Michela
    Lamantia, Giuseppina
    Colombo, Nicola
    Cortinovis, Sarah
    Dessanai, Maria A.
    Nole, Franco
    Veglia, Fabrizio
    Cipolla, Carlo M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (25) : 3910 - 3916
  • [39] Potential Ameliorating Role of Spironolactone in Trastuzumab-induced Cardiotoxicity: A Narrative Review
    Ghabousian, Amir
    Alizadehasl, Azin
    Ansari, Niloufar
    Haghazali, Mehrdad
    INTERNATIONAL JOURNAL OF MEDICAL TOXICOLOGY AND FORENSIC MEDICINE, 2022, 12 (02):
  • [40] IMPACT OF OVERWEIGHT ON ANTHRACYCLINE AND TRASTUZUMAB-INDUCED CARDIOTOXICITY: EXPERIMENTAL STUDY IN MICE
    Hachet, Olivier
    Aboutabl, Mona
    Rochette, Luc
    Vergely, Catherine
    Guenancia, Charles
    ACTA PHYSIOLOGICA, 2015, 214 : 56 - 56
12345